Freedom Capital Markets Maintains Buy on Hinge Health, Raises Price Target to $135
Benzinga Newsdesk 2 days ago
Analyst RatingsNewsPrice Target
Freedom Capital Markets analyst Gene Mannheimer maintains Hinge Health (NYSE:HNGE) with a Buy and raises the price target from $103 to $135.
Freedom Capital Markets analyst Gene Mannheimer maintains Hinge Health (NYSE:HNGE) with a Buy and raises the price target from $103 to $135.